言语识别率作为突发性聋疗效判定指标的研究进展

Research progress on speech recognition score as an indicator for evaluating the efficacy of treatment for sudden sensorineural hearing loss

摘要:

突发性聋(简称突聋)是耳科学常见的一种病因尚不明确的急性听力损失疾病，其发病率逐年上升。现有研究存在诸如纯音平均听阈(PTA)、眩晕或头晕、耳鸣、耳闷与生活质量改善等作为突聋疗效评定的指标，并且不同指南对同一指标也存在标准上的差别。缺乏统一的疗效判定指标及其标准，不利于对突聋的深入研究。言语识别率(SRS)具有独特的敏感性和实用性，美国已将其作为突聋患者听力疗效的判定指标，但我国尚未将SRS作为突聋疗效评判的具体标准。本文旨在探讨SRS用于判定突聋疗效的重要性及其研究进展。

Abstract:

Sudden sensorineural hearing loss (SSNHL), commonly known as sudden deafness, is an acute hearing loss disease in otology with an unclear etiology. Its incidence rate is increasing year by year. Current research utilizes various indicators to assess the efficacy of treatment for SSNHL, including pure tone audiometry (PTA),vertigo or dizziness, tinnitus, aural fullness, and improvement in quality of life. And there are also differences in standards for the same indicator among different guidelines. However, the absence of unified efficacy evaluation indicators and standards poses challenges to the homogeneous progression of research related to SSNHL. The speech recognition score (SRS), stands out due to its unique sensitivity and practicality, highlighting the necessity of its inclusion as a indicator for assessing hearing efficacy in patients with SSNHL in America. But SRS has not yet been adopted as a specific criterion for evaluating the therapeutic effect of SSNHL in China. This paper aims to explore the significance of SRS in evaluating the efficacy of SSNHL treatment.